1
Discover top-quality products tailored for scientific and medical research. Request a personalized quote today
to enhance your projects.
Species | Human |
Cat.No | ABC-X0053C |
Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
Product Category | Transfected Stable Cell Lines |
Size/Quantity | 1 vial |
Cell Type | Lymphocyte |
Shipping Info | Dry Ice |
Growth Conditions | 37 °C, 5% CO₂ |
Source Organ | Lymphatic |
Disease | Normal |
Biosafety Level | 1 |
Storage | Liquid Nitrogen |
Product Type | Overexpression Stable Cell Lines |
Host Cell | BAF3 |
Human TPR (Met_H1094Y) BAF3 Cell Line is a genetically engineered model derived from selected murine Ba/F3 parental cell line based on customers’ requirement. TPR (Met_H1094Y) BAF3 mutant cell line is generated through stable lentiviral transduction of human TPR gene fused with MET sequence and carrying the H1094Y mutation.
Target
TPR-MET is a fusion oncoprotein that results from chromosomal rearrangement, leading to constitutive activation of MET kinase signaling. The H1094Y mutation further enhances kinase activity and downstream oncogenic pathways such as RAS/MAPK and PI3K/AKT. This combination promotes cellular transformation and survival. AcceGen provides stable fusion and mutant models for studying targeted therapeutic strategies. Polyclonal or monoclonal is optional based on customers’ research needs.
For research use only